Matches in Nanopublications for { ?s ?p "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_provenance.
- NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_provenance.
- NP622826.RAQe087Akk2uGtVGaIv4z9DX4FixoHqguWzi33cjWAgbE130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622826.RAQe087Akk2uGtVGaIv4z9DX4FixoHqguWzi33cjWAgbE130_provenance.
- NP568988.RAPEj6qDdiUfGFWOZsC3-iBc8KPavew3Pi9ksaSKv0xmU130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568988.RAPEj6qDdiUfGFWOZsC3-iBc8KPavew3Pi9ksaSKv0xmU130_provenance.
- NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_provenance.
- NP671204.RAPDJu0gqqDIA333EOgLtRdtikZ_AdwmHvOWp4gt3jvVs130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671204.RAPDJu0gqqDIA333EOgLtRdtikZ_AdwmHvOWp4gt3jvVs130_provenance.
- NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_provenance.
- NP805964.RAggGi2huDD5v9-3R5rtLdoc8z_EKrb2lGKpmeG2WIojQ130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805964.RAggGi2huDD5v9-3R5rtLdoc8z_EKrb2lGKpmeG2WIojQ130_provenance.
- NP624143.RAMUZUgN16vmwV4VABMekUJhDjoECQ2EuucOoQdAn0Imo130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624143.RAMUZUgN16vmwV4VABMekUJhDjoECQ2EuucOoQdAn0Imo130_provenance.
- NP621537.RAx0GSzE4IubtpUPocxlJvgmu3yRoAGzfWe0vWnEPm4SY130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621537.RAx0GSzE4IubtpUPocxlJvgmu3yRoAGzfWe0vWnEPm4SY130_provenance.
- NP805965.RAxTPR4OhZ_6qCxCOg1yNAm3G1Awza7zNIHFcymG_6wwo130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805965.RAxTPR4OhZ_6qCxCOg1yNAm3G1Awza7zNIHFcymG_6wwo130_provenance.
- NP805967.RA_bHYKAGUof_PCl0f29X2-8VzhsrcAVQGpZ5MeLw2Moc130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805967.RA_bHYKAGUof_PCl0f29X2-8VzhsrcAVQGpZ5MeLw2Moc130_provenance.
- NP805968.RAywAhjkB4g5dAfgiGC7tDb4xwdm9MsdE69mhh35pWmLI130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805968.RAywAhjkB4g5dAfgiGC7tDb4xwdm9MsdE69mhh35pWmLI130_provenance.